RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Chronic Hepatitis B
Accession: DOID:9008163
browse the term
Definition: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Synonyms: primary_id: MESH:D019694
G
ADAR
adenosine deaminase RNA specific
treatment
ISO
DNA:SNP:enhancer: (rs4845384) (human)
RGD
PMID:24351124
RGD:125097515
NCBI chr 7:42,762,021...42,785,192
Ensembl chr 7:42,748,136...42,782,999
G
APOA1
apolipoprotein A1
ISO
protein:decreased expression mRNA, protein:decreased expression:liver, serum (human) protein:decreased expression:plasma (human)
RGD
PMID:21726101 PMID:25115832 PMID:27015844
RGD:25671432 RGD:25671433 RGD:5508214
NCBI chr 5:16,740,071...16,742,081
Ensembl chr 5:16,740,130...16,741,943
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:missense mutations:cds:p.C112R, p.R158C (human)
RGD
PMID:20961200
RGD:14401585
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
B9D2
B9 domain containing 2
no_association
ISO
DNA:SNPs:promoter:-509C>T (rs1800469) (human) DNA:SNPs, haplotypes: :869C>T (rs1800470), 11929C>T (rs1800472) (human)
RGD
PMID:28700046
RGD:14995436
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
BIRC3
baculoviral IAP repeat containing 3
ameliorates
ISO
RGD
PMID:25902529
RGD:152998939
NCBI chr 5:29,324,893...29,343,322
Ensembl chr 5:29,325,331...29,337,240
G
C2
complement C2
susceptibility
ISO
DNA:SNP:exon: p.Glu318Asp (human)
RGD
PMID:22610944
RGD:40886317
NCBI chr12:1,363,656...1,399,732
Ensembl chr12:1,363,803...1,399,728
G
CCL2
C-C motif chemokine ligand 2
ISO
protein:decreased expression:serum:
RGD
PMID:26281331
RGD:14995947
NCBI chr 9:39,008,187...39,009,932
G
CCL5
C-C motif chemokine ligand 5
severity
ISO
RGD
PMID:17711627
RGD:14995339
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
G
CCN2
cellular communication network factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17657819
NCBI chr 1:25,508,082...25,511,058
Ensembl chr 1:25,507,662...25,510,145
G
CD163
CD163 molecule
ISO
protein:increased expression:blood serum (human)
RGD
PMID:26339412
RGD:11251207
NCBI chr27:37,669,757...37,700,746
Ensembl chr27:37,669,827...37,753,106
G
CD1D
CD1d molecule
ISO
associated with hepatocellular carcinoma;mRNA:increased expression:liver (human)
RGD
PMID:29643189
RGD:127345114
NCBI chr38:23,489,169...23,491,712
G
CD274
CD274 molecule
treatment
ISO
protein:increased expression:regulatory T cell
RGD
PMID:20460044 PMID:26266813
RGD:11344683 RGD:41412166
NCBI chr 1:93,461,735...93,605,772
Ensembl chr 1:93,585,518...93,603,522
G
CEMIP2
cell migration inducing hyaluronidase 2
susceptibility
ISO
DNA:SNP:exon: p.Ser1254Asn (human)
RGD
PMID:22610944
RGD:40886317
NCBI chr 1:85,944,255...86,020,955
Ensembl chr 1:85,945,557...86,019,195
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility
ISO
DNA:SNP: :-318C>T(human)
RGD
PMID:16489681
RGD:14398727
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
G
CXCL10
C-X-C motif chemokine ligand 10
treatment
ISO
mRNA,protein:increased expression: peripheral blood mononuclear cell,serum, sinusoidal endothelium
RGD
PMID:18234638 PMID:30660173
RGD:27095888 RGD:27095951
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
G
CXCL8
C-X-C motif chemokine ligand 8
severity
ISO
mRNA, protein:increased expression:serum, peripheral blood mononuclear cell (human) associated with liver disease;mRNA, protein:increased expression:liver, blood serum (human)
RGD
PMID:23890815 PMID:26265888
RGD:11075958 RGD:150520196
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
DLA-DQB1
major histocompatibility complex, class II, DQ beta 1
treatment no_association
ISO
DNA:polymorphism: :HLA-DQB1*07(human) DNA:polymorphisms (human) DNA:polymorphisms: :multiple DNA:SNP: :rs2856718 (human)
RGD
PMID:16237774 PMID:16893387 PMID:28267888 PMID:29287219
RGD:14865012 RGD:14974232 RGD:36049762 RGD:5147637
NCBI chr12:2,305,307...2,307,711
G
DLA-DRB1
MHC class II DLA DRB1 beta chain
disease_progression susceptibility
ISO
DNA:haplotype:: DNA:polymorphisms: : DNA:polymorphism:cds:HLA-DRB1*07 (human)
RGD
PMID:16094724 PMID:16237774 PMID:16883532
RGD:14398840 RGD:36049762 RGD:40818403
NCBI chr12:2,151,409...2,164,564
G
EIF2AK3
eukaryotic translation initiation factor 2 alpha kinase 3
ISO
RGD
PMID:26234401
RGD:32716425
NCBI chr17:37,886,397...37,950,671
Ensembl chr17:37,886,601...37,949,812
G
FOXP3
forkhead box P3
ISO
mRNA,protein:increased expression:peripheral blood mononuclear cell, liver:
RGD
PMID:18673437 PMID:21489307
RGD:38548921 RGD:38549358
NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758
G
GPT
glutamic--pyruvic transaminase
treatment disease_progression
ISO
RGD
PMID:28007350 PMID:29279233
RGD:14975159 RGD:14975240
NCBI chr13:37,923,757...37,927,843
Ensembl chr13:37,924,422...37,926,156
G
IDO1
indoleamine 2,3-dioxygenase 1
ISO
protein:increased expression:serum (human)
RGD
PMID:28465467
RGD:39939037
NCBI chr16:25,391,759...25,407,161
Ensembl chr16:25,391,754...25,407,048
G
IFNG
interferon gamma
ISO
protein:decreased expression:serum (human)
RGD
PMID:26684441 PMID:28465467
RGD:14974255 RGD:39939037
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IL12A
interleukin 12A
ISO
mRNA:increased expression:liver
RGD
PMID:26062743
RGD:11097839
NCBI chr34:26,125,529...26,133,546
Ensembl chr34:26,124,770...26,133,550
G
IL12B
interleukin 12B
susceptibility
ISO
DNA:SNP:3'utr: (rs3212227)
RGD
PMID:25469587
RGD:11074616
NCBI chr 4:51,178,637...51,194,606
Ensembl chr 4:51,183,568...51,193,228
G
IL18
interleukin 18
disease_progression
ISO
DNA:SNP:promoter:-607C>A(human)
RGD
PMID:27470888
RGD:14696663
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
G
IL1RL1
interleukin 1 receptor like 1
severity
ISO
protein:increased expression:serum:
RGD
PMID:27180842 PMID:28381383
RGD:39457933 RGD:39938857
NCBI chr10:40,658,191...40,732,097
Ensembl chr10:40,659,041...40,677,357
G
IL2
interleukin 2
susceptibility
ISO
DNA:polymorphism:promoter:-385T>G(human)
RGD
PMID:19105930
RGD:14747034
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
G
IL21
interleukin 21
treatment susceptibility exacerbates
ISO
DNA:SNPs:introns: (rs2221903, rs907715) (human) DNA:SNP:intron: (rs2221903) (human) protein:decreased expression:blood serum (human) associated with non-alcoholic fatty liver disease protein:increased expression:blood serum (human)
RGD
PMID:23354321 PMID:25243706 PMID:26840345 PMID:28500636 PMID:29879024 PMID:30260401 PMID:31281514 PMID:32373234 More...
RGD:127285353 RGD:127285361 RGD:127285364 RGD:127285369 RGD:127285378 RGD:127285539 RGD:127285549 RGD:127285551
NCBI chr19:17,641,833...17,651,275
Ensembl chr19:17,641,833...17,651,266
G
IL29L
interleukin 29-like
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:21957142
RGD:126848748
NCBI chr24:36,440,445...36,441,017
Ensembl chr24:36,440,445...36,441,017
G
IL32
interleukin 32
exacerbates
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:22687868
RGD:150340733
NCBI chr 6:38,119,287...38,122,979
G
IL33
interleukin 33
severity treatment
ISO
RGD
PMID:25714983 PMID:27180842
RGD:39457933 RGD:39938954
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
IL4
interleukin 4
disease_progression treatment
ISO
DNA:SNP:promoter:-590C>T (human)
RGD
PMID:21331994 PMID:26281177
RGD:14696675 RGD:14696697
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
protein:increased expression:serum
RGD
PMID:24836184
RGD:40903002
G
JAK1
Janus kinase 1
disease_progression
ISO
DNA:SNPs: :rs4244165, rs17127024 (human)
RGD
PMID:22901011
RGD:19165132
NCBI chr 5:45,251,653...45,408,571
Ensembl chr 5:45,251,653...45,408,571
G
KEAP1
kelch like ECH associated protein 1
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:22459801
RGD:6892954
NCBI chr20:50,651,070...50,661,178
Ensembl chr20:50,650,711...50,658,496
G
KLRK1
killer cell lectin like receptor K1
susceptibility
ISO
DNA:SNP:intron 1:(rs2617160) (human)
RGD
PMID:20648603
RGD:39018553
NCBI chr27:35,634,938...35,658,978
Ensembl chr27:35,639,280...35,658,882
G
KRT18
keratin 18
severity disease_progression
ISO
protein:increased degradation:serum (human) protein:increased phosphorylation:liver (human)
RGD
PMID:20334631 PMID:28579343
RGD:18337487 RGD:18337494
NCBI chr27:2,189,269...2,193,368
Ensembl chr27:2,189,269...2,193,368
G
LEPR
leptin receptor
ISO
mRNA:altered expression:liver, peripheral blood mononuclear cell
RGD
PMID:17060687
RGD:21079470
NCBI chr 5:44,684,118...44,775,626
Ensembl chr 5:44,688,109...44,775,636
G
MBL1
mannose binding lectin 1
severity
ISO
DNA:haplotype: :
RGD
PMID:27824315
RGD:14696831
NCBI chr 4:29,419,886...29,424,377
G
MIR106B
microRNA mir-106b
severity
ISO
associated with hepatocellular carcinoma;miRNA:increased expression:liver (human)
RGD
PMID:27298561
RGD:15042853
NCBI chr 6:9,498,558...9,498,616
Ensembl chr 6:9,498,558...9,498,616
G
MIR155
microRNA mir-155
ISO
RGD
PMID:30735455
RGD:21081537
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR885
microRNA mir-885
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27738331
NCBI chr20:7,968,529...7,968,602
Ensembl chr20:7,968,529...7,968,602
G
MPL
MPL proto-oncogene, thrombopoietin receptor
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:28871230
RGD:150340590
NCBI chr15:16,815,102...16,825,321
Ensembl chr15:16,815,294...16,825,350
G
NCR1
natural cytotoxicity triggering receptor 1
severity disease_progression
ISO
protein:increased expression:Peripheral blood mononuclear cell, natural killer cell (human) protein:decreased expression:Peripheral blood mononuclear cell, natural killer cell (human) protein:decreased expression:peripheral blood mononuclear cell, natural killer cell (human)
RGD
PMID:26291078 PMID:28328926 PMID:29625837
RGD:39128177 RGD:40400737 RGD:40818237
NCBI chr 1:102,686,058...102,690,350
Ensembl chr 1:102,686,058...102,690,620
G
NFKBIA
NFKB inhibitor alpha
disease_progression
ISO
DNA:enhancers: :(rs2233406, rs2233409) (human)
RGD
PMID:29093318
RGD:127285389
NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
G
PDCD1
programmed cell death 1
disease_progression no_association
ISO
mRNA:increased expression:liver parenchyma (human) DNA:SNP:3' UTR:rs10204525(human) DNA:SNPs::+7146 G>A,+7209 C>T(human) DNA:SNP:exon: protein:altered expression:serum:
RGD
PMID:20700634 PMID:22634051 PMID:25736598 PMID:28983583 PMID:30016557
RGD:36947881 RGD:40818231 RGD:40818233 RGD:40818262 RGD:40818415
NCBI chr25:51,606,559...51,618,903
Ensembl chr25:51,608,173...51,618,723
G
PPP1R15A
protein phosphatase 1 regulatory subunit 15A
ISO
mRNA,protein:increased expression:liver
RGD
PMID:26234401
RGD:32716425
NCBI chr 1:107,486,399...107,490,151
Ensembl chr 1:107,486,438...107,489,222
G
PRDM1
PR/SET domain 1
disease_progression
ISO
RGD
PMID:31100710
RGD:150530465
NCBI chr12:63,454,242...63,495,278
Ensembl chr12:63,470,974...63,495,579
G
STAT2
signal transducer and activator of transcription 2
ISO
mRNA:decreased expression:monocyte (human)
RGD
PMID:30842274
RGD:41789632
NCBI chr10:641,543...660,882
Ensembl chr10:642,718...658,546
G
STAT4
signal transducer and activator of transcription 4
susceptibility
ISO
DNA:SNPs, haplotypes:multiple
RGD
PMID:25829184
RGD:25671420
NCBI chr37:1,566,563...1,685,378
Ensembl chr37:1,566,585...1,829,894
G
STING1
stimulator of interferon response cGAMP interactor 1
susceptibility
ISO
DNA:hypermethylation:promoter
RGD
PMID:30593207
RGD:39128221
NCBI chr 2:34,783,947...34,792,204
Ensembl chr 2:34,784,232...34,789,072
G
TAP1
transporter 1, ATP binding cassette subfamily B member
ISO
mRNA:decreased expression:blood
RGD
PMID:21843574
RGD:6482248
NCBI chr12:2,424,049...2,432,165
Ensembl chr12:2,378,126...2,432,303
G
TERT
telomerase reverse transcriptase
susceptibility
ISO
DNA:SNP, haplotype: :rs10069690,rs2242652(human)
RGD
PMID:29507683
RGD:14696786
NCBI chr34:11,288,622...11,307,790
Ensembl chr34:11,288,622...11,307,951
G
TLR2
toll like receptor 2
treatment disease_progression
ISO
protein:increased expression:serum:
RGD
PMID:25337250 PMID:25771704 PMID:28414577
RGD:15090812 RGD:15090826 RGD:15090828
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
G
TLR3
toll like receptor 3
susceptibility
ISO
DNA:SNP, haplotype: :1234C>T (human) DNA:snp: :rs3775290(human)
RGD
PMID:23076446 PMID:26024592
RGD:21079416 RGD:21079425
NCBI chr16:44,617,012...44,633,591
Ensembl chr16:44,550,846...44,653,247
G
TLR4
toll like receptor 4
ISO
protein:increased expression:serum:
RGD
PMID:28414577
RGD:15090812
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TLR9
toll like receptor 9
severity
ISO
mRNA, protein:decreased expression:peripheral blood mononuclear cell (human) DNA:SNPs: 5'UTR: (rs5743836, rs187084) (human) protein:increased expression:peripheral blood mononuclear cell (human) protein: increased expression:peripheral blood mononuclear cell (human) mRNA, protein: decreased expression:liver, CD14-positive monocyte (human)
RGD
PMID:18215354 PMID:19513613 PMID:24622882 PMID:27126946 PMID:30453064
RGD:18337464 RGD:18337467 RGD:18337470 RGD:18337472 RGD:18337474
NCBI chr20:37,529,322...37,547,117
Ensembl chr20:37,542,340...37,547,114 Ensembl chr20:37,542,340...37,547,114
G
TNFAIP3
TNF alpha induced protein 3
susceptibility
ISO
DNA:SNP,haplotypes: (rs148314165, rs200820567) (human)
RGD
PMID:28784141
RGD:151347613
NCBI chr 1:30,247,432...30,262,992
Ensembl chr 1:30,251,059...30,261,001
G
TNFSF13B
TNF superfamily member 13b
treatment
ISO
RGD
PMID:30660173
RGD:27095888
NCBI chr22:57,036,307...57,069,053
Ensembl chr22:57,036,292...57,068,320
G
UBE2L3
ubiquitin conjugating enzyme E2 L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24162738
NCBI chr26:30,835,222...30,899,842
Ensembl chr26:30,823,209...30,898,324
G
ZFHX3
zinc finger homeobox 3
ISO
protein:increased expression:blood serum (human)
RGD
PMID:20534899
RGD:151361169
NCBI chr 5:78,450,963...78,635,615
Ensembl chr 5:78,455,005...78,610,033
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all